Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Next generation cancer diagnostics Market expected to reach $20.93 billion by 2022

Monday, November 14, 2016 10:19
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Global Next Generation Cancer Diagnostics Industry

Global Next Generation Cancer Diagnostics market is estimated at $2.95 billion in 2015 and is expected to grow at a CAGR of 32.6% to reach $20.93 billion by 2022. Growing incidence of oncology diseases is expected to boost the demand for next generation cancer diagnostic tests market. However, lack of sufficient reimbursement policies for novel technologies and stringent regulatory procedures are the major factors that can hamper the global next generation cancer diagnostics market growth over the forecast period. 

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/456549-next-generation-cancer-diagnostics-global-market-outlook

The largest segment of the global market for next generation cancer diagnostics is Blood-born cancers. Asia Pacific is likely to be one of the fastest growing regions of this sector and is anticipated to grow at a lucrative rate. A largely untouched market base which has exhibited technological advancements in healthcare research during the past decade is responsible for rapid growth in this region. 

Some of the key players in the global Next Generation Cancer Diagnostics market are Thermo Fisher Scientific, Inc., Roche, Philips Electronics NV, Perkin Elmer Inc., Novartis AG, Lab-on-a-chip, Illumina, Inc., Agilent Technologies Inc, Siemens Healthcare, Johnson & Johnson, Hologic Inc., GE Healthcare, C.R. Bard, Inc and Abbot. 

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=456544

Cancer Type Covered: 
• Lung Cancer 
• Colorectal Cancer 
• Cervical Cancer 
• Breast Cancer 
• Other Cancer Types 
Functions Covered: 
• Therapeutic Monitoring 
• Risk analysis 
• Prognostics diagnosis 
• Companion Diagnostics 
• Cancer Screening 
Technologies Covered: 
• Platform-Based Diagnostics 
o Polymerase Chain Reaction (PCR) 
o Next-Generation Sequencing (NGS) 
o Microarrays 
o In Situ Hybridization (ISH) 
o Immunohistochemistry (IHC) 
o Flow Cytometry 
o Other Technologies 
• Instrument-Based 
o Diagnostic Imaging 
o Ultrasound 
o Mammography 
• Biopsies 
Regions Covered: 
• North America 
o US 
o Canada 
o Mexico 
• Europe 
o Germany 
o France 
o Italy 
o UK 
o Spain 
o Rest of Europe 
• Asia Pacific 
o Japan 
o China 
o India 
o Australia 
o New Zealand 
o Rest of Asia Pacific 
• Rest of the World 
o Middle East 
o Brazil 
o Argentina 
o South Africa 
o Egypt

For Detailed Reading Please visit WiseGuy Reports @  https://www.wiseguyreports.com/reports/456549-next-generation-cancer-diagnostics-global-market-outlook

What our report offers: 
- Market share assessments for the regional and country level segments 
- Market share analysis of the top industry players 
- Strategic recommendations for the new entrants 
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets 
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
- Strategic recommendations in key business segments based on the market estimations 
- Competitive landscaping mapping the key common trends 
- Company profiling with detailed strategies, financials, and recent developments 
- Supply chain trends mapping the latest technological advancements

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.